As coronavirus vaccines and treatments advance rapidly through research and development, the world starts to consider what drugs and digital tools might be needed in the ‘new normal’.
Professor Paul Kaye from the University of York, whose research team was recently granted €8 million to help reduce the burden of leishmaniasis in African countries, takes us through the lo
Harvard University launched LabXchange in January and the free science education platform acquired new resonance during the COVID-19 lockdowns that saw millions of students around the world